SECsense Logo

Dynavax Technologies 8-K Report: Key Updates for Investors (Feb 2025)

$DVAX
Form 8-K
Filed on: 2025-02-20
Source
Dynavax Technologies 8-K Report: Key Updates for Investors (Feb 2025)

Based on the provided XML section of the financial report, here are the key extracted details and insights:

  1. Entity Information:
  • Company Name: Dynavax Technologies Corporation
  • CIK (Central Index Key): 0001029142
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-34207
  • IRS Employer Identification Number: 33-0728374
  • Address: 2100 Powell Street, Suite 720, Emeryville, CA 94608
  • Phone Number: 510-848-5100
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 20, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Ticker Symbol: DVAX
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: February 20, 2025
  • End Date: February 20, 2025

Insights:

  • The report is a current report (Form 8-K) indicating that Dynavax Technologies Corporation is disclosing information that is important for shareholders and potential investors.
  • The reporting period is a single day, which might suggest a specific event or announcement relevant to that date, warranting immediate disclosure.
  • The presence of the entity's CIK and IRS numbers indicates compliance with SEC regulations, ensuring transparency and accessibility of the company's information.

This information could be crucial for stakeholders interested in the company's financial health, stock performance, and any significant developments that occurred on the filing date.